/
ELAN
$23.67+$1.16 (+5.15%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$11.1B
500M shares
52-week range
$17.11 – $27.98
60% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Change$-7.86
Elanco Animal Health Incorporated Common Stock
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
www.elanco.com- Employees
- 9,900
- IPO / List date
- Sep 20, 2018
- HQ
- INDIANAPOLIS, IN
Held by traders on TradeandTell
No one on the platform currently holds ELAN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 86,190 | $2.1M |
| Renaissance Technologiesas of 2025-03-31 | 33,144 | $348.0K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded ELAN yet.
